EdgarLookup

Gain Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Islam Khalid Executive Chairman Purchase 50,000 $1.00 $50,000 50,000 Aug 9, 2024
Mack Gene CFO and Interim CEO Purchase 14,400 $1.01 $14,544 14,400 Aug 9, 2024
RICHMAN ERIC I Purchase 12,000 $1.21 $14,520 289,629 Jul 1, 2024
Riley Jeffrey Scott Purchase 30,000 $3.86 $115,800 30,000 Mar 28, 2024
Alder Matthias Chief Executive Officer Option Exercise 637 27,225 Mar 26, 2024
Alder Matthias Chief Executive Officer Sale 206 $2.46 $507 5,286 Dec 20, 2023
Alder Matthias Chief Executive Officer Sale 1,820 $2.50 $4,550 4,855 Dec 7, 2023
Alder Matthias Chief Executive Officer Option Exercise 825 6,675 Oct 1, 2023
RICHMAN ERIC I Option Exercise 54,900 272,629 Sep 20, 2023
Alder Matthias Chief Executive Officer Option Exercise 2,550 5,850 Sep 20, 2023
Alder Matthias Chief Executive Officer Option Exercise 3,300 3,300 Jul 1, 2023
RICHMAN ERIC I CHIEF EXECUTIVE OFFICER Purchase 2,482 $2.58 $6,404 217,729 May 25, 2022
Calabrese Salvatore CHIEF FINANCIAL OFFICER Purchase 3,000 $8,100.00 $24,300,000 May 19, 2022
Calabrese Salvatore CHIEF FINANCIAL OFFICER Purchase 3,000 $2.70 $8,100 3,000 May 19, 2022
RICHMAN ERIC I CHIEF EXECUTIVE OFFICER Purchase 9,256 $2.83 $26,194 215,247 May 19, 2022
RICHMAN ERIC I Option Exercise 4,922 $7.87 $38,736 216,820 Aug 16, 2021
RICHMAN ERIC I Chief Executive Officer Purchase 4,922 $7.87 $38,736 216,820 Aug 16, 2021